ストックスクリーナーアプリを入手
5.4593
3.53%
-0.2107
Abcellera Biologics Inc (ABCL) 最新ニュース
ABCL|Abcellera Biologics Inc|Price:5.665|Chg%:-0.065 - TradingKey
ABCL Stock Clocks Best Week Since February On Clinical Data Anticipation, Baker Bros Stake Boost - Stocktwits
Playing The Biotech Breakout With Insiders - Seeking Alpha
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers - marketscreener.com
Abcellera Biologics, Inc. (ABCL) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Abcellera Biologics, Inc. (ABCL) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Abcellera Biologics, Inc. (ABCL) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Abcellera Biologics, Inc. (8QQ) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Abcellera Biologics, Inc. (8QQ) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Abcellera Biologics, Inc. (8QQ) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Abcellera Biologics, Inc. (8QQ) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Does AbCellera’s New Board Appointment Reframe Its Execution Story for Investors in ABCL? - simplywall.st
Wall Street Analysts Believe ABCELLERA BIOLG (ABCL) Could Rally 97.28%: Here's is How to Trade - MSN
ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill
Cantor Fitzgerald reiterates Overweight on AbCellera stock at $11 By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Overweight on AbCellera stock at $11 - Investing.com UK
symbol__ Stock Quote Price and Forecast - CNN
JonesTrading Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $13 - Moomoo
ABCL Stock Price and Chart — NASDAQ:ABCL - TradingView
Weekly Recap: Lynn Seely board appointment and Benchmark upgrade to Buy - TradingView
AbCellera Biologics Stock (ABCL) Opinions on Jazz Partnership and Analyst Upgrade - Quiver Quantitative
Has ABCELLERA BIOLG (ABCL) Outpaced Other Medical Stocks This Year? - MSN
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains? - MSN
AbCellera Biologics (ABCL) TD Cowen 46th Annual Health Care Conference Summary - Quartr
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026 - BNN Bloomberg
Are you looking for a top momentum pick? Why AbCellera Biologics Inc. (ABCL) is a great choice - MSN
AbCellera Biologics (ABCL) Q4 2024 earnings summary - Quartr
Press Release: AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026 - Moomoo
AbCellera Appoints Dr. Victor Sandor to its Board of Directors - AOL.com
Are You Looking for a Top Momentum Pick? Why AbCellera Biologics Inc. (ABCL) is a Great Choice - Yahoo Finance
Benchmark Upgrades AbCellera Biologics to Buy From Hold, Price Target Is $11 - Moomoo
AbCellera Biologics Price Target Announced at $11.00/Share by Benchmark - Moomoo
AbCellera Biologics Raised to Buy From Hold by Benchmark - Moomoo
What AbCellera Biologics (ABCL)'s New Oncology Veteran Director Means For Shareholders - simplywall.st
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Seely Lynn - Moomoo
[Form 4] AbCellera Biologics Inc. Insider Trading Activity - Stock Titan
AbCellera (ABCL) director Lynn Seely submits initial Form 3 insider ownership filing - Stock Titan
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Sandor Victor - Moomoo
Lynn Seely appointed to AbCellera Board as Class III director - TradingView
Dr. Lynn Seely joins AbCellera (NASDAQ: ABCL) board as independent director - Stock Titan
AbCellera appoints Lynn Seely to board of directors By Investing.com - Investing.com South Africa
AbCellera appoints Lynn Seely to board of directors - Investing.com
AbCellera Appoints Dr. Lynn Seely to its Board of Directors - Yahoo Finance
Is ABCELLERA BIOLG (ABCL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is AbCellera Biologics (ABCL) One of the Best Stocks with Biggest Upside? - Yahoo Finance
0.68%
大文字化:
|
ボリューム (24 時間):